Search - tctmd.com

Displaying 181 - 200 of 302

Sort: Relevancy | Date

Presentation TCT 2017

Case #4: Trans-septal Entry Through Fontan and Mustard Baffles (With Discussion)

Presenter: Lee N. Benson, Frank F. Ing, Mark Osten

October 30, 2017

Presentation TCT 2017

Case #2: Venous Recannulation (With Discussion)

Presenter: Lee N. Benson, Frank F. Ing

October 30, 2017

Presentation TCT 2017

Case #1: Coarctation of the Aorta: Tips, Tricks, and Pitfalls (With Discussion)

Presenter: Lee N. Benson, Frank F. Ing

October 30, 2017

Presentation iASSESS 2017

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Rahul Sakhuja, Zoltan Turi

August 30, 2017

Presentation iASSESS 2017

Congenital Heart Disease

Presenter: John P. Breinholt

August 30, 2017

Presentation ECHO 2017

Approach to Congenital Heart Disease II: Evaluating the Post-operative Adult

Presenter: Karen Stout

April 02, 2017

Presentation ECHO 2017

Echocardiographic Approach to Congenital Heart Disease I: Evaluating the Unoperated Adult

Presenter: Karen Stout

April 02, 2017

Presentation SIF 2017

Watchman Implantation Case

Presenter: Michael J. Lim

March 09, 2017

Presentation Miami Valves 2017

Structural Training in Three Continents: A New Paradigm for a New Specialty

Presenter: Pablo A. Rengifo-Moreno

January 31, 2017

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

The RoPE Score: How to select pathologic PFO?

Presenter: John D. Carroll, Christian Spies, David E. Thaler

November 01, 2016

Presentation TCT 2016

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Long-term Outcomes of Coarctation Stenting

Presenter: John D. Carroll, Thomas J Forbes

November 01, 2016

Presentation TCT 2016

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Presenter: John D. Carroll, Thomas J Forbes, Elchanan Bruckheimer

November 01, 2016

Advertisement

Case #4: Trans-septal Entry Through Fontan and Mustard Baffles (With Discussion)

Case #2: Venous Recannulation (With Discussion)

Case #1: Coarctation of the Aorta: Tips, Tricks, and Pitfalls (With Discussion)

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Congenital Heart Disease

Approach to Congenital Heart Disease II: Evaluating the Post-operative Adult

Echocardiographic Approach to Congenital Heart Disease I: Evaluating the Unoperated Adult

Watchman Implantation Case

Structural Training in Three Continents: A New Paradigm for a New Specialty

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

The RoPE Score: How to select pathologic PFO?

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Long-term Outcomes of Coarctation Stenting

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content